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Abstract
Introduction:  We report an unusual and interesting case of a 24-year-old woman with
nephropathic cystinosis in association with concomitant isolated noncompaction of the left
ventricle. Left ventricular noncompaction usually presents with reduced exercise tolerance as a
consequence of ventricular dysfunction, the result of embolus or with palpitations and syncope due
to arrhythmia. There is no specific treatment directed at isolated noncompaction. Treatment is
focused on the cause of presentation, with medication aimed at improving ventricular dysfunction,
as well as treating and preventing thrombosis and arrhythmia.
Case presentation: Our patient presented with an episode of decompensated heart failure.
Trans-thoracic echocardiography demonstrated excessive trabeculation with inter-trabecular
recesses in the left ventricle typical of noncompaction of the left ventricle. The patient's admission
was complicated by a cardiac arrest precipitated by ventricular tachycardia for which she
subsequently underwent implantation of an automatic implantable cardioverter defibrillator.
Conclusion: This is, as far as we know, the first case report of the co-existence of nephropathic
cystinosis and isolated noncompaction of the left ventricle. It highlights the importance of being
vigilant to the diagnosis of left ventricular noncompaction.
Introduction
Isolated noncompaction of the left ventricle (LV) is
increasingly being recognized as a distinct entity with a
significant associated morbidity and mortality; however,
definitions are still being debated. A diagnosis can be
made with the commonly available modality of echocar-
diography but is still often overlooked. The co-existence
of noncompaction of the LV together with nephropathic
cystinosis has not been described previously.
Case presentation
A 24-year-old woman with cystinosis complicated by end-
stage renal failure, for which she was receiving intermit-
tent haemodialysis, was admitted with generalized
malaise and weight loss. In May 2001, she had undergone
trans-thoracic echocardiography because of increasing
shortness of breath on exertion, and this had shown a
moderately dilated LV with globally reduced systolic func-
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tion (ejection fraction, EF = 25%), consistent with dilated
cardiomyopathy.
The patient was referred for cardiology consultation fol-
lowing a period of increased breathlessness and a cardiac
arrest precipitated by ventricular tachycardia from which
she was successfully DC cardioverted. Her medication at
that time included perindopril 4 mg once daily (od),
carvedilol 3.125 mg twice daily (bd), prednisolone 5 mg
od, levothyroxine 200 mcg od, folic acid 5 mg od, darbe-
poetin 80 mcg per week, mercaptamine (Cystagon) 150
mg four times per day (qds), calcium carbonate 500 mg
three times daily (tds), aspirin 75 mg od and alfacalcidol
1.5 mcg od.
On examination, the patient's blood pressure was 86/50
mmHg and she was in sinus rhythm at 76 bpm. She had
some facial oedema, mild ankle oedema and bi-basal
crackles on chest auscultation. Heart sounds examination
revealed a soft apical pansystolic murmur. The remainder
of the examination was unremarkable. Echocardiography
revealed a dilated LV with globally impaired systolic LV
function (EF Simpsons biplane = 25%). There was marked
trabeculation of the LV, most prominent at the apex and
lateral wall at the mid-ventricular level; six trabeculae
were more than 2 mm in diameter. The noncompacted to
compacted ratio was 2.2 at the thickest part of the lateral
wall on the parasternal short-axis view. Multiple inter-
trabecular recesses in communication with the LV cavity
were demonstrated by forward and reverse flow of blood
on colour flow mapping (Figure 1). These features are
consistent with current diagnostic criteria for isolated ven-
tricular noncompaction. At the time of writing, the patient
had been referred for heart and kidney transplant assess-
ment and had undergone implantation of an automatic
implantable cardioverter defibrillator (AICD).
Discussion
The first cases of cystinosis were reported in 1903 [1].
Cystinosis is an autosomal recessively inherited lysosomal
storage disorder. The genetic mutation has been located
on the short arm of chromosome 17 [2]. There is a failure
of the normal export of cystine from the lysosome, lead-
ing to cystine accumulation in almost all cells, with varia-
ble consequences on the ability of that tissue to function
normally.
Three variants have been described. These are the nephro-
pathic, the adolescent, and the benign adult forms. Our
patient had the nephropathic variant.
Skeletal muscle involvement has been widely reported.
Muscle cystine concentrations approximately a thousand-
fold greater than normal values are reported [3]. Cystine
crystals have not been found within the myocytes them-
selves but in the perimysial and endomysial spaces [3].
The influence this has on the myocyte is unknown, but
interestingly, there are reports of selective atrophy of type
1 muscle fibres in the skeletal muscle of patients with
cystinosis [3]. Cystine concentrations in cardiac muscle
have been shown to be of the same order of magnitude as
those found in skeletal muscle in patients affected with
cystinosis [3], and it is possible that in the absence of ther-
apy, cystine accumulation may lead to a macroscopically
hypertrophied myocardium [4] with prominent trabecu-
lae. There is no obvious reason to believe that cardiac
muscle would be affected any differently to skeletal mus-
cle.
Isolated ventricular noncompaction is increasingly recog-
nised as a distinct entity with an associated significant
morbidity and mortality. It was the third most commonly
identified primary cardiomyopathy in an epidemiological
survey of Australian children, after dilated and hyper-
trophic cardiomyopathy [5]. However, a lack of an under-
standing of its pathophysiological origins, combined with
a lack of consistent diagnostic criteria, has led to this con-
dition being under-diagnosed and frequently missed. Iso-
lated noncompaction of the ventricular myocardium may
manifest itself any time from infancy to adulthood but
most commonly occurs in adulthood, with men and
women being affected equally frequently. Embryologi-
cally, the myocardium begins as a loose meshwork of
interwoven myocardial fibres. These fibres condense and
become compacted; this process begins in the epicardium
and progresses towards the endocardium, and from the
base toward the apex. It is commonly believed that it is the
arrest of this compacting process during weeks 5–8 of
embryogenesis that leads to this condition. Consistent
with this is the common finding of noncompaction affect-
ing the apex and endocardium. This leads to the com-
monly held belief that isolated LV noncompaction is a
congenital disease; however, reports of LV noncompac-
tion are accumulating [6]. In the majority of patients, it is
the LV that is involved. Right ventricular involvement is
difficult to be certain of, as prominent trabeculation may
be a normal variant [7].
Isolated noncompaction may occur sporadically or be
inherited. Familial adult and neonatal forms have been
described. The familial adult forms of the disease are
transmitted as an autosomal, dominant trait in the major-
ity of cases [8]. Neonatal forms of isolated ventricular
noncompaction can be linked to mutations affecting the
X chromosome associated with Barth syndrome [9], X-
linked endocardial fibroelastosis and other X-linked
infantile cardiomyopathies.
Clinically, patients may present with a triad of symptoms,
related to LV dysfunction, arrhythmia presenting as palpi-Journal of Medical Case Reports 2009, 3:31 http://www.jmedicalcasereports.com/content/3/1/31
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Trans-thoracic echocardiography of our patient, demonstrating prominent trabeculation with colour-flow mapping demon- strating blood flow into the deep intertrabecular recesses in the left ventricle Figure 1
Trans-thoracic echocardiography of our patient, demonstrating prominent trabeculation with colour-flow 
mapping demonstrating blood flow into the deep intertrabecular recesses in the left ventricle.Journal of Medical Case Reports 2009, 3:31 http://www.jmedicalcasereports.com/content/3/1/31
Page 4 of 5
(page number not for citation purposes)
tations and syncope, or with the consequences of systemic
thrombo-embolism. Others may be asymptomatic and
identified incidentally. LV systolic dysfunction is one of
the most commonly occurring features [7,10-13]. The
concept of microvascular disease as a mechanism for ven-
tricular dysfunction is supported by the finding of
ischemic subendocardial lesions in these patients [14].
Diastolic dysfunction has been described. It is suggested
that this relates to the multiple prominent trabeculations,
causing restrictive filling and intrinsic abnormal ventricu-
lar relaxation [15].
Diagnosis is most commonly made by two-dimensional
and colour Doppler echocardiography. Commonly used
criteria include the identification of excessive (more than
three), prominent (more than 2 mm diameter) trabeculae
with inter-trabecular recesses that penetrate deeply into
the myocardium, from which blood flows directly into
and out of the ventricular cavity (which is demonstrated
using colour Doppler imaging), in the absence of other
structural heart disease.
More objective criteria have been validated by Jenni et al.
[14]. This group found that a ratio of greater than two of
the end-systolic noncompacted endocardial layer, in the
parasternal short axis view, to the compacted epicardial
layer of myocardium using echocardiography was diag-
nostic. They validated this against autopsy specimens of
the same myocardium.
Areas of noncompaction are found predominantly in the
apex and midventricular regions of the inferior and lateral
walls, with the trabeculae most frequently coursing from
the free wall to the ventricular septum [16]. Hypokinesis
of affected and unaffected myocardium is not unusual,
with globally reduced ventricular function.
Alternative conditions with reported prominent trabecu-
lations include hypetrophic cardiomyopathy, endocardial
fibroelastosis and metastatic disease involving the myo-
cardium. More than three prominent trabeculations is
unusual in the normal ventricle [6].
Prognosis is variable. Patients not uncommonly experi-
ence sudden death, progression of their ventricular dys-
function, arrhythmias such as ventricular tachycardia, or
atrial fibrillation. Thrombo-embolic complications, sec-
ondary to atrial fibrillation or thrombus in the deep
recesses, are common. Many patients may also remain
asymptomatic.
Management is as for heart failure, including arrhythmia
management, and more liberal use of prophylactic antico-
agulation agents. Increased awareness of possible compli-
cations will allow earlier institution of correct therapies.
AICD therapy for haemodynamically significant arrhyth-
mia and cardiac transplantation should be considered.
Conclusion
This is the first report to our knowledge of LV noncompac-
tion in a patient with cystinosis. It highlights the impor-
tance of being vigilant to the diagnosis of LV
noncompaction in such patients.
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